In-hospital results of therapy with the NGLT-2 inhibitor dapagliflozin in patients with acute decompensation of heart failure: prospective randomized study

BACKGROUND: This study focuses on the development of new approaches to the management of patients with acute decompensation of heart failure (ADHF) using sodium-glucose cotransporter type 2 (iHLT-2) inhibitors, particularly dapagliflozin, and its role in early treatment initiation. AIM: Our aim w...

Полное описание

Библиографические подробности

Главные авторы:	Omar M. Omarov, Grigorij G. Arabidze, Zaur S. Shogenov, Elena A. Petrik
Формат:	Artigo
Язык:	Inglês
Опубликовано:	Concilium Medicum 2024-04-01
Серии:	КардиоСоматика
Предметы:	dapagliflozin type 2 sodium-glucose cotransporter inhibitors acute decompensation of chronic heart failure ejection fraction
Online-ссылка:	https://cardiosomatics.ru/2221-7185/article/viewFile/622928/pdf
Метки:	Добавить метку Нет меток, Требуется 1-ая метка записи!